Comprehensive exploration of the role of multimodal programmed cell death- associated lncRNAs in the prognosis and immunity of glioma - Takeaways - MDSpire

Comprehensive exploration of the role of multimodal programmed cell death- associated lncRNAs in the prognosis and immunity of glioma

  • By

  • Shuaishuai Wu

  • Xiangji Meng

  • Yanran Hu

  • Qi Wang

  • Yanfen Yao

  • Haiyan Jia

  • Zhen Ma

  • Yang Liu

  • Zhongxu Sun

  • Yahu Bai

  • Haixia Jin

  • Lingzhi Li

  • Changli Wang

  • May 14, 2026

  • 0 min

Share

  • 1

    Gliomas have a poor prognosis, necessitating novel biomarkers and therapeutic approaches to improve patient outcomes.

  • 2

    The study developed a prognostic risk framework based on lncRNAs associated with programmed cell death pathways.

  • 3

    AC092718.4 significantly influences glioma cell proliferation and invasion, highlighting its potential as a therapeutic target.

  • 4

    Programmed cell death pathways are interconnected and play a crucial role in tumor development and treatment resistance.

  • 5

    LncRNAs are key regulators of programmed cell death in CNS tumors, impacting tumor initiation and progression.

Original Source(s)

Comprehensive exploration of the role of multimodal programmed cell death- associated lncRNAs in the prognosis and immunity of glioma

  • by Shuaishuai Wu, Xiangji Meng, Yanran Hu, Qi Wang, Yanfen Yao, Haiyan Jia, Zhen Ma, Yang Liu, Zhongxu Sun, Yahu Bai, Haixia Jin, Lingzhi Li, Changli Wang

  • May 14, 2026

Related Content

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

High-grade astrocytoma with piloid features: a case report of comprehensive management

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series